SCHEMBL23347339

SCHEMBL23347339

c1cc2c3c(cccc3c1)-c1cc3c(cc1-2)c(-c1cccc2sccc12)cc1c2cc4c(cc2c(-c2cccc5sccc25)cc31)-c1cccc2cccc-4c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 4/20 0.44
ALDH1A1 P00352 4/20 0.44
TSHR P16473 3/20 0.44
MAPK1 P28482 3/20 0.44
CASP1 P29466 3/20 0.44
CASP7 P55210 2/20 0.44
HPGD P15428 2/20 0.44
HIF1A Q16665 2/20 0.44
TP53 P04637 1/20 0.44
PABPC1 P11940 2/20 0.41
DNMT1 P26358 2/20 0.41
ADRA2A P08913 1/20 0.41
ADRA2B P18089 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.39
ATM Q13315 1/20 0.39
CYP3A4 P08684 1/20 0.33
CES2 O00748 1/20 0.33
BCHE P06276 1/20 0.33
CES1 P23141 1/20 0.33
MCL1 Q07820 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23347340 0.88 ALDH1A1 (0.35) HSD17B10ALDH1A1TSHRMAPK1CASP1
SCHEMBL23347392 0.79 HSD17B10 (0.46) HSD17B10ALDH1A1TSHRMAPK1CASP1
SCHEMBL5153625 0.78 ADRA2A (0.56) ALDH1A1HPGDADRA2AADRA2BPOLQ
SCHEMBL23347380 0.77 HSD17B10 (0.41) HSD17B10ALDH1A1TSHRMAPK1CASP1
SCHEMBL28846891 0.75 ADRA2A (0.47) HSD17B10ALDH1A1TSHRHPGDADRA2A
SCHEMBL23347338 0.75 ALDH1A1 (0.36) HSD17B10ALDH1A1TSHRMAPK1CASP1
SCHEMBL23347102 0.74 ALDH1A1 (0.48) HSD17B10ALDH1A1TSHRMAPK1CASP1
SCHEMBL21187775 0.74 HSD17B10 (0.57) HSD17B10ALDH1A1TSHRMAPK1CASP1
SCHEMBL23347323 0.72 ALOX5 (0.51) HSD17B10ALDH1A1TSHRMAPK1CASP1
SCHEMBL405253 0.70 ALDH1A1 (0.70) HSD17B10ALDH1A1TSHRMAPK1CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11844268-B2 Organic compound and organic light-emitting element CANON KABUSHIKI KAISHA (JP) 2023-12-12 US disclosed
US-11844268-B2 Organic compound and organic light-emitting element CANON KABUSHIKI KAISHA (JP) 2023-12-12 US disclosed
US-20210143335-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT CANON KABUSHIKI KAISHA (JP) 2021-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11844268-B2 Organic compound and organic light-emitting element OR51E2, OR10J3, NR2E3 HSD17B10 560/4885ALDH1A1 151/4885TSHR 2943/4885
US-20210143335-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT OR51E2, OR10J3, NR2E3 HSD17B10 560/4885ALDH1A1 151/4885TSHR 2943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.